Hattie Hayes

The Finnish company shared technical specifications for the ST500

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

Rick Lewis, MD, speaks about a non-pharmaceutical approach to treating glaucoma with laser technology

The ESCRS Moving Simulator initiative brings surgical training to nations in need

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain

A postcard from the American Society of Retina Specialists meeting in Stockholm

In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

John Thompson, MD, discusses long-term results of using ICG to peel ILM in the treatment of macular holes

Carl C. Awh, MD, FASRS, gives an overview of the Phase 3 Pagoda trial year 2 results

This year, the ASRS meeting will feature an expert panel on sustainability — learn more from panelist Martin Zinkernagel, MD, PhD

Jennifer I. Lim, MD, FARVO, FASRS, discusses her ASRS presentation, "Differential Artery-Vein Analysis Improves OCTA Performance for Artificial Intelligence Classification of Diabetic Retinopathy"

The organisation has secured £72.75 million for its new eye health centre

Faricimab is already approved in the EU and UK for neovascular age-related macular degeneration and diabetic macular oedema

The prize, presented by EURETINA and supported by Oculis, will recognise outstanding contributions to retina research

The diagnostic and monitoring tools use artificial intelligence-based models

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

ARVO attendees took a deep dive into trends and explored the near future of vision science

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

Surgeons shared practical pearls in a “Cataract Olympiad"

This year’s meeting will take place in Ireland’s technology and business hub

The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress

The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen

The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March

Three leaders in glaucoma research, retina care and refractive surgery share their expertise

Antonio Filipe Macedo, OD, MSc, PhD, speaks about his ARVO presentation on vision-related activity difficulties in patients with neovascular age-related macular degeneration

New research findings presented at this year's ARVO meeting compare two groups of paediatric patients in Nepal